KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung-Reference-Cited by-同舟云学术

KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung

Published:2021-04-13 Issue:3 Volume:16 Page:169-176
ISSN:1862-040X
Container-title:Der Nephrologe
language:de
Short-container-title:Nephrologe

Author:

Busch Martin,Mann Johannes,Wolf Gunter

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11560-021-00498-y.pdf

Reference10 articles.

1. Kidney Disease: Improving global outcomes (KDIGO) Diabetes Workgroup (2020) Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 98(4S):S1–S115

2. de Boer IH, Caramori ML, Chan JCN et al (2020) Executive summary of the 2020 KDIGO Diabetes Management in CKD-Guideline: evidence-based advances in monitoring and treatment. Kidney Int 98:839–848

3. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2021) KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99(3S):1–87

4. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group (2013) KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl 3:259–305

5. Bakris GL, Agarwal R, Anker SD et al (2020) Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383:2219–2229

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung – Update 2022;Die Nephrologie;2023-04-21

2. Therapieoptionen bei diabetischer Nephropathie;Die Diabetologie;2023-02-21

3. Antidiabetika zur Progressionshemmung der Nephropathie;Der Nephrologe;2021-07-28